ICU Medical
Open
$117.78
Prev. Close
$117.78
High
$117.85
Low
$117.78
Market Snapshot
$2.85B
3893.5
-4.84
$2.38B
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
emptyResult
ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
Recently from Cashu
ICU Medical (ICUI) Schedules Q4 Earnings Release Feb. 19, 2026 at 4:05 p.m. ET
ICU Medical timestamps quarter-end disclosure ICU Medical (NASDAQ: ICUI) releases its fourth-quarter earnings statement on Thursday, Feb. 19, 2026 at 4:05 p.m. ET, completing its formal reporting for…
ICU Medical earnings release is operational checkpoint for infusion franchise, margins and R&D
Earnings release frames operational checkpoint for infusion specialist ICU Medical is set to publish its quarterly results on Thursday, 2026-02-19, delivering a concise operational update that stakeho…
ICU Medical Quarterly Results Preview: Product Adoption, Margin Initiatives and Guidance on Feb. 19
ICU Medical prepares to report operating results in a closely watched quarterly filing that market participants treat as an update on recent commercial and margin trends rather than a pure financial e…
ICU Medical Earnings Preview: Infusion Therapy Adoption, Margin Trajectory, Supply-Chain and R&D
Earnings Briefing Ahead of Thursday Release ICU Medical is set to release its quarterly results on Thursday, 2026-02-19, and expects the filing to serve as a compact operational update for the medical…